Company performance
Current Price
as of Jan 21, 2025$2.02
P/E Ratio
16.61
Market Cap
$89.57M
Loading...
Description
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). It offers Metformin HCI and Metformin DC. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.
Metrics
Overview
- HQOslo, PS
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerVISTN
- Price$2.019821+1.56%
Trading Information
- Market cap$89.57M
- Float46.78%
- Average Daily Volume (1m)9,050
- Average Daily Volume (3m)10,302
- EPS$1.39
Company
- Revenue$426.52M
- Rev growth (1yr)-11.76%
- Net income$16.56M
- Gross margin22.74%
- EBITDA margin27.24%
- EBITDA$28.83M
- EV$1.24B
- EV/Revenue2.90
- P/E16.61
- P/S2.39
- P/B3.28
Documents
Factset